Trial intelligence / Profile preview

Prednisolone vs Placebo in Modified CAC Model

NCT01730872Phase 4Completed

Start
Nov 2012
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of prednisolone sodium phosphate in allergic conjunctivitis (AC). Started Nov 2012; status: completed.

02

Drugs

prednisolone sodium phosphate
03

Conditions

allergic conjunctivitis (AC)

Beyond the preview

Go deeper on NCT01730872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01730872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call